Efficacy of sagenit in menopausal syndrome

Resumo

A double-blind placebo-controlled multicenter study of Sagenit was conducted in menopausal patients. Thirty-four women received the drug as a tablet (0.1 g) daily. Therapy was performed for 9 months. Placebo was also given to 36 patients during the same period. Sagenit turned out to be highly effective in abolishing neurovegetative and psychoemotional symptoms. Even when used long continuously for 9 months, the agent caused no adverse reactions, such as endometrial proliferation, and had no effect on the breast. Thus, the use of sagenit may be an alternative to hormonal replacement therapy.